[F110. A liquid formulation—U.K.
(a)containing cannabidiol obtained by extraction and purification from cannabis;
(b)where the concentration of—
(i)delta-9-tetrahydrocannabinol is not more than 0.1 milligram per millilitre; and
(ii)cannabidiol is 95-105 milligrams per millilitre;
(c)which is presented in a bottle, as an oral solution for oral administration; and
(d)which was approved for marketing by the European Commission on 19th September 2019. ]
Textual Amendments